LPL enhancement genetic mimicry was also associated with decreased migraine risk in both FinnGen (OR = 0.82, 95% CI: 0.69–0.96, p = 0.01) and Choquet datasets (OR = 0.91, 95% CI: 0.83–0.99, p = 0.03). Here, LPL is linked to migraine disorder.